University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

New research has discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and ...

The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...

For the first time, scientists have identified the specific cells that allow severely damaged tissue to regenerate after ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA's Fast Track designation for ateganosine ...

Medical researchers typically play the long game, spending years (and years and years) exploring an idea that could move ...

AbelZeta announces AstraZeneca agreed to acquire AbelZeta’s 50% share of China development and commercialization rights to C-CAR031: Rockville, Maryland Tuesday, January 20, 202 ...

Moderna & Merck announce 5-year data for intismeran autogene in combo with Keytruda demonstrated sustained improvement in primary endpoint of recurrence-free survival in patients with high-risk stage ...

Organ transplants are a "never-ending tragedy," with referrals steadily going up while the number of organs available remains ...

The judge in the aggravated murder case against William P. Long Jr., who’s accused of killing his ex-wife, denied two defense ...